Corporate news
FDA Approves Grifols New GamaSTAN® (immune globulin [human]) to Treat Patients Exposed to Hepatitis A and Measles GamaSTAN is the only immune globulin product on the U.S. market approved for immediate protection against HAV and measles.
+ info
+ info
Grifols Announces Winner of the 2018 SPIN Award for Immunoglobulin Research in Neurology at the 2018 Peripheral Nerve Society Annual Meeting The 2018 SPIN Award was presented to Miriam Fichtner, from Yale University, to support her research project "IVIg influence on pathogenic B cells in myasthenia gravis"
+ info
+ info
Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System Procleix Zika Virus assay provides U.S. blood banks the ability to screen blood donations for the presence of the Zika virus and improve blood transfusion safety
+ info
+ info
Highlights
Manufacturing
We are a solid company with an international dimension.
Corporate Commitment
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.
When a Dream Comes True. An Illustrated History of 75 Years of Grifols
Read When a Dream Comes True: An illustrated history of 75 years of Grifols to discover the company's roots, and learn more about our history and the development of the company. + info